What is Transact Technologies Inc's earnings per share (EPS)?

Transact Technologies Inc (TACT) reported diluted earnings per share of -$0.12 for fiscal year 2025. This represents a 87.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Transact Technologies Inc (TACT) Financials

TACT

Trailing 12 months to June 30, 2026

Revenue $53.0M +10.5% YoY

Net Income -$400K +95.4% YoY

EPS (Diluted) -$0.04 +95.3% YoY

Free Cash Flow $5.2M -13.4% YoY

Market Cap $47.4M as of Oct 8, 2026

Price / Sales 0.9x on $53.0M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.5x on $32.7M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TACT SEC filings page.

Transact Technologies Inc (TACT) reported $53.0M in revenue over the twelve months to Jun 30, 2026, up 10.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TACT FY2025 2026-10-03

The business rebounded from FY2024’s slump, but cash generation improved faster than accounting earnings while margins remain below FY2023 levels.

FY2025 operating cash flow of $7.7M exceeded reported net income of -$1.2M, showing cash conversion was better than earnings. That gap coincided with inventory falling from $16.2M to $10.9M, so cash generation appears tied more to working-capital release than profitability.

Gross margin was 48.6% versus 52.9% in FY2023, revealing the recovery did not restore prior product economics. Operating margin improved to -2.8% from -8.4%, indicating better fixed-cost absorption even while the business remained unprofitable.

Liabilities were $13.7M against $44.8M of assets, leaving the company financed more by equity than obligations rather than by heavy debt. A 3.0x current ratio and 0.4x debt-to-equity ratio point to substantial short-term coverage and restrained leverage, limiting balance-sheet amplification of losses.

Financial Health Signals

Financial Health Score 48/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Transact Technologies Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Transact Technologies Inc held $20.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $7.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Transact Technologies Inc scores 86/100 among other emerging companies.

Dilution

Transact Technologies Inc had 10M shares outstanding at the end of fiscal year 2025, against 10M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Transact Technologies Inc scores 67/100 among other emerging companies.

R&D Intensity

Transact Technologies Inc spent $6.7M on research and development in fiscal year 2025, which was 12.7% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Transact Technologies Inc scores 41/100 among other emerging companies.

Revenue Progress

Transact Technologies Inc reported revenue of $51.5M in fiscal year 2025, against $43.4M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Transact Technologies Inc scores 24/100 among other emerging companies.

Burn Trend

Not available for Transact Technologies Inc, and counted as zero in the overall score.

Balance Sheet

Transact Technologies Inc's cash, cash equivalents and investments came to $20.4M at the end of fiscal year 2025, against $13.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Transact Technologies Inc scores 69/100 among other emerging companies.

Altman Z-Score Safe

3.92

Transact Technologies Inc scores 3.92, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($47.4M) relative to total liabilities ($13.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/8

Transact Technologies Inc passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

Transact Technologies Inc reported a net loss of $1.2M while generating $7.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Transact Technologies Inc reported an operating loss of $1.4M against $339K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$13.9M

YoY+1.1%

QoQ-3.2%

5Y CAGR+8.4%

10Y CAGR-0.6%

Transact Technologies Inc generated $13.9M in revenue in Q2 2026. This represents an increase of 1.1% from the same quarter a year earlier. Against the prior quarter it is down 3.2%.

EBITDA

$84K

YoY+196.6%

QoQ-91.0%

Transact Technologies Inc's EBITDA was $84K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 196.6% from the same quarter a year earlier. Against the prior quarter it is down 91.0%.

Net Income

-$50K

YoY+65.0%

QoQ-106.5%

Transact Technologies Inc reported -$50K in net income in Q2 2026. This represents an increase of 65.0% from the same quarter a year earlier. Against the prior quarter it is down 106.5%.

EPS (Diluted)

$0.00

YoY+100.0%

QoQ-100.0%

Transact Technologies Inc earned $0.00 per diluted share (EPS) in Q2 2026. This represents an increase of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Cash & Balance Sheet

Free Cash Flow

$2.1M

YoY-41.3%

QoQ+304.5%

10Y CAGR+0.4%

Transact Technologies Inc generated $2.1M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 41.3% from the same quarter a year earlier. Against the prior quarter it is up 304.5%.

Cash & Debt

$19.4M

YoY+9.2%

QoQ+2.9%

5Y CAGR+19.5%

10Y CAGR+22.5%

Transact Technologies Inc held $19.4M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

10M

YoY+2.3%

QoQ+0.5%

5Y CAGR+2.8%

Transact Technologies Inc had 10M shares outstanding in Q2 2026. This represents an increase of 2.3% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

50.2%

YoY+2.0pp

QoQ-0.1pp

5Y change+13.4pp

10Y change+9.8pp

Transact Technologies Inc's gross margin was 50.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Operating Margin

-0.4%

YoY+1.5pp

QoQ-5.7pp

Transact Technologies Inc's operating margin was -0.4% in Q2 2026, reflecting core business profitability. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.7 percentage points.

Net Margin

-0.4%

YoY+0.7pp

QoQ-5.7pp

5Y change+21.4pp

10Y change-5.5pp

Transact Technologies Inc's net profit margin was -0.4% in Q2 2026, showing the share of revenue converted to profit. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.7 percentage points.

Return on Equity

-0.1%

YoY+0.3pp

QoQ-2.5pp

5Y change+7.4pp

10Y change-3.3pp

Transact Technologies Inc's ROE was -0.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.

Capital Allocation

R&D Spending

$1.2M

YoY-28.9%

QoQ-11.2%

Transact Technologies Inc invested $1.2M in research and development in Q2 2026. This represents a decrease of 28.9% from the same quarter a year earlier. Against the prior quarter it is down 11.2%.

Capital Expenditures

$57K

YoY+200.0%

QoQ-28.7%

5Y CAGR-8.9%

10Y CAGR-6.3%

Transact Technologies Inc invested $57K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 200.0% from the same quarter a year earlier. Against the prior quarter it is down 28.7%.

Share Buybacks

Not reported for Q2 2026.

TACT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TACT quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$53.0M	$51.5M+18.7%	$43.4M-40.3%	$72.6M+24.9%	$58.1M+47.6%	$39.4M+28.7%	$30.6M-33.1%	$45.7M-16.2%	$54.6M-3.1%	$56.3M-1.6%	$57.2M-4.1%	$59.7M+12.4%	$53.1M-11.7%	$60.1M-12.1%	$68.4M+3.7%	$66.0M
Cost of Revenue	N/A	$26.5M+20.8%	$21.9M-36.0%	$34.2M+1.5%	$33.7M+40.5%	$24.0M+35.9%	$17.7M-25.8%	$23.8M-14.5%	$27.8M-6.1%	$29.6M-11.3%	$33.4M-3.6%	$34.7M+10.5%	$31.4M-10.4%	$35.0M-17.3%	$42.4M+2.6%	$41.3M
Gross Profit	$26.3M	$25.0M+16.4%	$21.5M-44.1%	$38.4M+57.3%	$24.4M+58.7%	$15.4M+19.0%	$12.9M-41.1%	$21.9M-18.0%	$26.7M+0.3%	$26.7M+12.0%	$23.8M-4.7%	$25.0M+15.0%	$21.7M-13.5%	$25.1M-3.4%	$26.0M+5.5%	$24.6M
R&D Expenses	N/A	$6.7M-4.0%	$7.0M-26.1%	$9.4M+10.2%	$8.6M+14.6%	$7.5M+31.1%	$5.7M+29.8%	$4.4M-4.0%	$4.6M+6.3%	$4.3M-2.8%	$4.4M+23.0%	$3.6M-16.3%	$4.3M+5.8%	$4.1M-4.1%	$4.2M+24.0%	$3.4M
SG&A Expenses	N/A	$11.3M+13.7%	$9.9M-25.4%	$13.3M+9.2%	$12.2M+26.7%	$9.6M+4.0%	$9.3M+1.0%	$9.2M+11.7%	$8.2M+2.8%	$8.0M+9.9%	$7.3M-1.4%	$7.4M-5.0%	$7.8M+17.7%	$6.6M-15.9%	$7.8M+2.6%	$7.6M
Operating Income	N/A	-$1.4M+61.0%	-$3.6M-163.5%	$5.7M+174.3%	-$7.7M+18.1%	-$9.4M-14.7%	-$8.2M-2482.8%	$343K-94.9%	$6.8M-0.8%	$6.8M+31.0%	$5.2M+16.4%	$4.5M+218.5%	-$3.8M-157.0%	$6.6M+18.1%	$5.6M-19.8%	$7.0M
EBITDA	N/A	-$743K+71.3%	-$2.6M-136.0%	$7.2M+213.4%	-$6.3M+24.6%	-$8.4M-23.3%	-$6.8M-498.5%	$1.7M-77.9%	$7.8M-1.8%	$7.9M+20.9%	$6.5M+10.8%	$5.9M+353.3%	-$2.3M-127.8%	$8.4M+13.6%	$7.4M-14.4%	$8.6M
Interest Expense	N/A	$339K+5.3%	$322K+3.9%	$310K+49.0%	$208K+32.5%	$157K+20.8%	$130K+364.3%	$28K+3.7%	$27K-18.2%	$33K0.0%	$33K-10.8%	$37K-39.3%	$61K-4.7%	$64K+4.9%	$61K-11.6%	$69K
Income Tax	N/A	$156K-97.5%	$6.3M+445.0%	$1.2M+158.8%	-$2.0M+3.8%	-$2.0M+19.6%	-$2.5M-1604.0%	-$149K-114.3%	$1.0M-70.8%	$3.6M+129.3%	$1.6M+15.0%	$1.4M+194.2%	-$1.4M-189.8%	$1.6M-18.7%	$2.0M-15.8%	$2.3M
Net Income	-$400K	-$1.2M+87.4%	-$9.9M-307.7%	$4.7M+180.0%	-$5.9M-46.9%	-$4.0M+28.2%	-$5.6M-1191.1%	$516K-90.5%	$5.4M+69.0%	$3.2M-11.2%	$3.6M+17.0%	$3.1M+227.7%	-$2.4M-149.1%	$4.9M+36.3%	$3.6M-22.6%	$4.7M
EPS (Basic)	N/A	-$0.12+87.9%	-$0.99-306.3%	$0.48+180.0%	-$0.60-39.5%	-$0.43+40.3%	-$0.72-1128.6%	$0.07-90.4%	$0.73+69.8%	$0.43-10.4%	$0.48+20.0%	$0.40+237.9%	-$0.29-150.9%	$0.57+42.5%	$0.40-20.0%	$0.50
EPS (Diluted)	-$0.04	-$0.12+87.9%	-$0.99-310.6%	$0.47+178.3%	-$0.60-39.5%	-$0.43+40.3%	-$0.72-1128.6%	$0.07-90.0%	$0.70+66.7%	$0.42-10.6%	$0.47+20.5%	$0.39+234.5%	-$0.29-150.9%	$0.57+42.5%	$0.40-18.4%	$0.49
Diluted Shares (Avg)	N/A	10M+0.9%	10M-0.2%	10M+1.2%	10M+6.5%	9M+18.8%	8M+2.0%	8M-1.1%	8M+2.2%	8M-0.8%	8M-2.5%	8M-5.5%	8M-4.6%	9M-4.6%	9M-5.0%	10M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$13.9M+1.1%	$14.4M+10.4%	$11.5M+11.9%	$13.2M+21.2%	$13.8M+19.0%	$13.1M+22.1%	$10.2M-22.9%	$10.9M-36.8%
Cost of Revenue	$6.9M-2.8%	$7.2M+7.0%	N/A	$6.6M+17.4%	$7.1M+30.2%	$6.7M+32.2%	N/A	$5.6M-31.8%
Gross Profit	$7.0M+5.3%	$7.3M+14.1%	$5.4M+20.5%	$6.6M+25.4%	$6.7M+8.9%	$6.4M+13.1%	$4.5M-29.0%	$5.2M-41.4%
R&D Expenses	$1.2M-28.9%	$1.4M-15.6%	N/A	$1.7M+1.0%	$1.7M-4.1%	$1.6M-16.8%	N/A	$1.6M-34.6%
SG&A Expenses	$3.1M+0.4%	$2.9M+9.5%	N/A	$2.8M+9.9%	$3.1M+20.8%	$2.7M-7.7%	N/A	$2.5M-9.8%
Operating Income	-$54K+79.1%	$771K+5240.0%	N/A	$14K+101.7%	-$258K+41.1%	-$15K+98.8%	N/A	-$837K-170.3%
EBITDA	$84K+196.6%	$929K+488.0%	N/A	$177K+128.1%	-$87K+55.8%	$158K+117.4%	N/A	-$629K-140.0%
Income Tax	$30K-25.0%	$23K-54.9%	N/A	$25K+116.9%	$40K+146.5%	$51K+118.4%	N/A	-$148K-187.6%
Net Income	-$50K+65.0%	$766K+3931.6%	-$1.1M+85.8%	$15K+102.7%	-$143K+55.2%	$19K+101.8%	-$8.0M-12733.9%	-$551K-160.8%
EPS (Basic)	$0.00+100.0%	$0.08	-$0.11+86.1%	$0.00+100.0%	-$0.01+66.7%	$0.00+100.0%	-$0.79-7800.0%	-$0.06-166.7%
EPS (Diluted)	$0.00+100.0%	$0.07	-$0.11+86.1%	$0.00+100.0%	-$0.01+66.7%	$0.00+100.0%	-$0.79	-$0.06-166.7%
Diluted Shares (Avg)	10M+2.0%	10M+1.8%	N/A	10M+1.5%	10M+0.9%	10M+0.8%	N/A	10M-0.5%

Not reported in any period shown, so not listed: Interest Expense.

TACT Balance Sheet

TACT quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$44.8M+1.7%	$44.0M-18.8%	$54.2M+4.6%	$51.8M+1.8%	$50.9M+20.6%	$42.2M+17.2%	$36.1M+3.2%	$35.0M+3.0%	$34.0M+6.0%	$32.0M-1.6%	$32.6M-8.2%	$35.5M-12.2%	$40.4M-10.7%	$45.2M+5.8%	$42.7M
Current Assets	$38.8M+1.2%	$38.4M-6.4%	$41.0M+13.5%	$36.1M-2.7%	$37.1M+31.8%	$28.2M+13.1%	$24.9M-7.8%	$27.0M+2.6%	$26.4M+13.8%	$23.2M-0.9%	$23.4M-16.5%	$28.0M-13.1%	$32.2M-9.7%	$35.7M+8.0%	$33.1M
Cash & Equivalents	$20.4M+42.0%	$14.4M+16.8%	$12.3M+55.1%	$7.9M-59.2%	$19.5M+87.8%	$10.4M+146.5%	$4.2M-10.4%	$4.7M-14.8%	$5.5M+120.0%	$2.5M-44.0%	$4.5M+42.9%	$3.1M+6.6%	$2.9M-61.0%	$7.5M+9.8%	$6.9M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$10.9M-32.8%	$16.2M-9.0%	$17.8M+47.6%	$12.0M+56.0%	$7.7M-31.7%	$11.3M-6.7%	$12.1M-5.7%	$12.8M+44.6%	$8.9M-8.6%	$9.7M-14.1%	$11.3M-4.3%	$11.8M-12.6%	$13.5M+30.9%	$10.3M-27.1%	$14.2M
Accounts Receivable	$6.4M-2.2%	$6.5M-33.8%	$9.8M-29.5%	$13.9M+83.4%	$7.6M+124.8%	$3.4M-47.4%	$6.4M-20.0%	$8.0M	N/A	N/A	$7.2M-21.1%	$9.1M-31.3%	$13.2M-16.9%	$15.9M+66.2%	$9.6M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M+4.1%	$2.5M
Total Liabilities	$13.7M+1.9%	$13.4M-9.4%	$14.8M-17.7%	$18.0M+50.4%	$11.9M-0.5%	$12.0M+18.5%	$10.1M+37.2%	$7.4M-6.9%	$7.9M0.0%	$7.9M+16.0%	$6.8M-32.2%	$10.1M+28.0%	$7.9M-33.5%	$11.9M+59.7%	$7.4M
Current Liabilities	$13.0M+1.3%	$12.9M-5.5%	$13.6M-14.4%	$15.9M+62.6%	$9.8M+46.3%	$6.7M-12.4%	$7.6M+15.3%	$6.6M-9.8%	$7.3M-1.0%	$7.4M+17.3%	$6.3M-34.3%	$9.6M+31.1%	$7.3M-28.0%	$10.2M+75.0%	$5.8M
Non-Current Liabilities	$605K+17.0%	$517K-55.0%	$1.1M-43.8%	$2.0M-5.1%	$2.2M-59.5%	$5.3M+113.5%	$2.5M+228.8%	$757K+29.0%	$587K+15.3%	$509K-0.6%	$512K+11.1%	$461K-14.2%	$537K-67.5%	$1.7M+3.6%	$1.6M
Total Equity	$31.1M+1.6%	$30.6M-22.3%	$39.4M+16.4%	$33.9M-13.1%	$39.0M+29.4%	$30.1M+16.2%	$25.9M-6.0%	$27.6M+6.0%	$26.0M+7.9%	$24.1M-6.3%	$25.7M+1.3%	$25.4M-21.9%	$32.5M-2.5%	$33.4M-5.5%	$35.3M
Retained Earnings	$3.3M-27.5%	$4.5M-68.6%	$14.4M+49.3%	$9.6M-38.1%	$15.6M-20.6%	$19.6M-22.6%	$25.3M-7.9%	$27.5M+11.1%	$24.8M+2.5%	$24.2M+5.2%	$23.0M+2.7%	$22.3M-18.2%	$27.3M+10.6%	$24.7M+14.3%	$21.6M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$51.0M+14.5%	$47.9M+8.4%	$44.8M+1.7%	$45.0M-10.9%	$44.5M-11.5%	$44.2M-14.9%	$44.0M-18.8%	$50.5M-10.9%
Current Assets	$40.6M+2.2%	$38.7M-0.5%	$38.8M+1.2%	$39.2M+4.7%	$39.7M+7.2%	$38.9M+0.1%	$38.4M-6.4%	$37.4M-12.3%
Cash & Equivalents	$19.4M+9.2%	$18.8M+32.9%	$20.4M+42.0%	$20.0M+76.7%	$17.7M+59.4%	$14.2M+33.4%	$14.4M+16.8%	$11.3M-2.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$9.1M-29.9%	$9.6M-33.6%	$10.9M-32.8%	$11.7M-30.4%	$13.0M-26.5%	$14.4M-24.8%	$16.2M-9.0%	$16.9M-4.0%
Accounts Receivable	$10.4M+32.7%	$9.0M-0.4%	$6.4M-2.2%	$5.8M-21.3%	$7.8M+15.8%	$9.1M+16.5%	$6.5M-33.8%	$7.4M-39.1%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%	$2.6M0.0%
Total Liabilities	$18.3M+38.3%	$15.6M+18.0%	$13.7M+1.9%	$13.2M+8.7%	$13.3M+12.1%	$13.2M-0.9%	$13.4M-9.4%	$12.1M-30.5%
Current Liabilities	$15.3M+18.7%	$12.4M-3.0%	$13.0M+1.3%	$12.8M+14.0%	$12.9M+20.2%	$12.8M+2.3%	$12.9M-5.5%	$11.3M-30.1%
Non-Current Liabilities	$3.0M+704.7%	$3.2M+585.6%	$605K+17.0%	$379K-57.7%	$379K-66.0%	$471K-46.4%	$517K-55.0%	$897K-35.3%
Total Equity	$32.7M+4.4%	$32.3M+4.4%	$31.1M+1.6%	$31.8M-17.1%	$31.3M-18.8%	$30.9M-19.8%	$30.6M-22.3%	$38.4M-2.1%
Retained Earnings	$4.0M-9.1%	$4.0M-10.9%	$3.3M-27.5%	$4.4M-64.7%	$4.4M-66.3%	$4.5M-66.0%	$4.5M-68.6%	$12.5M-13.6%

Not reported in any period shown, so not listed: Long-Term Debt.

TACT Cash Flow Statement

TACT quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$5.4M	$7.7M+312.3%	$1.9M-66.2%	$5.5M+145.1%	-$12.2M-386.9%	-$2.5M+28.5%	-$3.5M-172.4%	$4.8M-5.1%	$5.1M-13.7%	$5.9M+28.0%	$4.6M-16.7%	$5.6M-8.3%	$6.1M+142.8%	$2.5M-69.0%	$8.0M+283.1%	$2.1M
Depreciation & Amortization	N/A	$672K-35.2%	$1.0M-30.4%	$1.5M+11.8%	$1.3M+39.2%	$957K-28.7%	$1.3M-2.1%	$1.4M+37.5%	$997K-7.8%	$1.1M-18.8%	$1.3M-6.7%	$1.4M-1.3%	$1.4M-17.0%	$1.7M-1.0%	$1.8M+9.3%	$1.6M
Stock-Based Compensation	N/A	$1.8M+55.7%	$1.2M+34.5%	$860K-25.5%	$1.2M-4.2%	$1.2M+37.7%	$876K+26.6%	$692K+10.0%	$629K+3.3%	$609K-0.3%	$611K+25.2%	$488K-3.6%	$506K-2.9%	$521K+0.2%	$520K-11.4%	$587K
Capital Expenditures	$217K	$109K-66.1%	$322K-64.3%	$901K-30.6%	$1.3M-6.1%	$1.4M+86.0%	$744K-29.9%	$1.1M+5.5%	$1.0M+20.6%	$835K+37.3%	$608K-36.6%	$959K+45.3%	$660K-6.9%	$709K-34.5%	$1.1M+69.1%	$640K
Free Cash Flow	$5.2M	$7.6M+391.5%	$1.5M-66.6%	$4.6M+134.1%	-$13.5M-247.2%	-$3.9M+8.5%	-$4.3M-212.4%	$3.8M-7.8%	$4.1M-19.3%	$5.1M+26.6%	$4.0M-12.5%	$4.6M-14.9%	$5.4M+202.3%	$1.8M-74.3%	$6.9M+377.2%	$1.5M
Investing Cash Flow	-$3.7M	-$1.6M-400.6%	-$322K+64.3%	-$901K+30.6%	-$1.3M-685.1%	$222K+116.5%	-$1.3M+43.2%	-$2.4M-60.6%	-$1.5M-49.5%	-$985K-64.2%	-$600K+37.2%	-$955K-44.7%	-$660K+11.5%	-$746K+32.3%	-$1.1M+79.0%	-$5.3M
Financing Cash Flow	-$162K	-$119K-118.8%	$634K+828.7%	-$87K-104.2%	$2.1M-82.0%	$11.5M+4.0%	$11.0M+480.8%	-$2.9M+35.9%	-$4.5M-135.3%	-$1.9M+67.8%	-$6.0M-84.0%	-$3.2M+37.4%	-$5.2M+18.3%	-$6.3M-1.5%	-$6.2M-397.8%	-$1.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$2.7M+0.6%	$2.7M+3.3%	$2.6M+6.8%	$2.4M-2.8%	$2.5M-2.8%	$2.6M+10.3%	$2.3M+340.5%	$526K	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$2.0M+458.7%	$358K-90.0%	$3.6M+250.1%	$1.0M-61.3%	$2.6M-49.3%	$5.2M-12.5%	$5.9M+121.6%	$2.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$2.2M-40.1%	-$946K-487.6%	$609K-74.5%	$3.6M+1010.1%	$3.6M+465.3%	-$161K+89.2%	$2.4M+160.7%	$327K-63.7%
Depreciation & Amortization	$138K-19.3%	$158K-8.7%	$165K-14.5%	$163K-21.6%	$171K-29.0%	$173K-56.2%	$193K-50.0%	$208K-45.4%
Stock-Based Compensation	$455K+1.1%	$511K+58.2%	N/A	$527K+60.2%	$450K+61.3%	$323K+21.9%	N/A	$329K
Capital Expenditures	$57K+200.0%	$80K+700.0%	$20K+81.8%	$60K-11.8%	$19K-86.1%	$10K-90.6%	$11K-90.3%	$68K-31.3%
Free Cash Flow	$2.1M-41.3%	-$1.0M-500.0%	$589K-75.2%	$3.6M+1278.4%	$3.6M+616.6%	-$171K+89.3%	$2.4M+196.0%	$259K-67.7%
Investing Cash Flow	-$1.6M-8057.9%	-$560K-5500.0%	-$171K-1454.5%	-$1.4M-1976.5%	-$19K+86.1%	-$10K+90.6%	-$11K+90.3%	-$68K+31.3%
Financing Cash Flow	-$24K	-$69K-38.0%	-$35K-105.0%	-$34K	$0	-$50K+29.6%	$705K+70600.0%	$0

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TACT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TACT quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	48.6%-0.9pp	49.5%-3.3pp	52.9%+10.9pp	42.0%+2.9pp	39.1%-3.2pp	42.3%-5.7pp	47.9%-1.0pp	49.0%+1.6pp	47.3%+5.8pp	41.6%-0.3pp	41.9%+1.0pp	40.9%-0.8pp	41.7%+3.7pp	38.0%+0.7pp	37.3%
Operating Margin	-2.8%+5.6pp	-8.4%-16.2pp	7.9%+21.1pp	-13.2%+10.6pp	-23.8%+2.9pp	-26.7%-27.5pp	0.8%-11.6pp	12.4%+0.3pp	12.1%+3.0pp	9.1%+1.6pp	7.5%+14.6pp	-7.1%-18.1pp	11.0%+2.8pp	8.2%-2.4pp	10.6%
Net Margin	-2.4%+20.3pp	-22.7%-29.3pp	6.5%+16.8pp	-10.2%+0.1pp	-10.3%+8.1pp	-18.4%-19.5pp	1.1%-8.8pp	9.9%+4.2pp	5.7%-0.6pp	6.3%+1.1pp	5.2%+9.7pp	-4.6%-12.8pp	8.2%+2.9pp	5.3%-1.8pp	7.1%
Return on Equity	-4.0%+28.2pp	-32.2%-44.3pp	12.0%+29.6pp	-17.5%-7.2pp	-10.4%+8.3pp	-18.7%-20.7pp	2.0%-17.7pp	19.7%+7.3pp	12.3%-2.7pp	15.0%+3.0pp	12.0%+21.6pp	-9.5%-24.7pp	15.2%+4.3pp	10.8%-2.4pp	13.2%
Return on Assets	-2.8%+19.6pp	-22.4%-31.2pp	8.8%+20.2pp	-11.5%-3.5pp	-7.9%+5.4pp	-13.3%-14.8pp	1.4%-14.1pp	15.5%+6.1pp	9.5%-1.8pp	11.3%+1.8pp	9.5%+16.3pp	-6.8%-19.0pp	12.2%+4.2pp	8.0%-2.9pp	10.9%
Current Ratio	2.970.0x	2.980.0x	3.01+0.7x	2.27-1.5x	3.79-0.4x	4.21+0.9x	3.26-0.8x	4.08+0.5x	3.59+0.5x	3.12-0.6x	3.69+0.8x	2.91-1.5x	4.38+0.9x	3.50-2.2x	5.67
Debt-to-Equity	0.440.0x	0.44+0.1x	0.38-0.2x	0.53+0.2x	0.31-0.1x	0.400.0x	0.39+0.1x	0.270.0x	0.310.0x	0.33+0.1x	0.27-0.1x	0.40+0.2x	0.24-0.1x	0.36+0.1x	0.21
Asset Turnover	1.15+0.2x	0.99-0.4x	1.34+0.2x	1.12+0.3x	0.770.0x	0.72-0.5x	1.27-0.3x	1.56-0.1x	1.66-0.1x	1.790.0x	1.83+0.3x	1.500.0x	1.490.0x	1.510.0x	1.54
FCF Margin	14.7%+11.1pp	3.5%-2.8pp	6.3%+29.6pp	-23.3%-13.4pp	-9.9%+4.0pp	-13.9%-22.2pp	8.3%+0.8pp	7.5%-1.5pp	9.0%+2.0pp	7.0%-0.7pp	7.7%-2.5pp	10.2%+7.2pp	3.0%-7.2pp	10.2%+7.9pp	2.2%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Gross Margin	50.2%+2.0pp	50.3%+1.6pp	47.6%+3.4pp	49.8%+1.7pp	48.2%-4.5pp	48.7%-3.9pp	44.2%-3.8pp	48.1%-3.8pp
Operating Margin	-0.4%+1.5pp	5.3%+5.5pp	N/A	0.1%+7.8pp	-1.9%+1.9pp	-0.1%+12.1pp	N/A	-7.7%-14.6pp
Net Margin	-0.4%+0.7pp	5.3%+5.2pp	-9.9%+67.9pp	0.1%+5.2pp	-1.0%+1.7pp	0.1%+9.8pp	-77.8%-77.3pp	-5.1%-10.3pp
Return on Equity	-0.1%+0.3pp	2.4%+2.3pp	-3.6%+22.3pp	0.1%+1.5pp	-0.5%+0.4pp	0.1%+2.8pp	-26.0%-25.8pp	-1.4%-3.8pp
Return on Assets	-0.1%+0.2pp	1.6%+1.6pp	-2.5%+15.5pp	0.0%+1.1pp	-0.3%+0.3pp	0.0%+2.0pp	-18.1%-18.0pp	-1.1%-2.7pp
Current Ratio	2.65-0.4x	3.13+0.1x	2.970.0x	3.05-0.3x	3.08-0.4x	3.05-0.1x	2.980.0x	3.32+0.7x
Debt-to-Equity	0.56+0.1x	0.48+0.1x	0.440.0x	0.42+0.1x	0.42+0.1x	0.43+0.1x	0.44+0.1x	0.32-0.1x
Asset Turnover	0.270.0x	0.300.0x	0.260.0x	0.29+0.1x	0.31+0.1x	0.30+0.1x	0.230.0x	0.22-0.1x
FCF Margin	15.0%-10.9pp	-7.1%-5.8pp	5.1%-18.1pp	27.1%+24.7pp	25.9%+21.6pp	-1.3%+13.6pp	23.2%+17.2pp	2.4%-2.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Transact Technologies Inc TACT	FY2025	$51.5M	-$1.2M	-2.4%	$47.4M	48/100
ZSPACE INC NEW ZSPC	FY2025	$27.9M	-$25.4M	-91.1%	$1.3M	—
KEY Tronic Corp KTCC	FY2026	$386.7M	-$47.8M	-12.4%	$24.0M	29/100
Ebang International Holdings Inc. EBON	FY2025	$6.5M	-$14.1M	N/A	$11.9M	59/100
BTC Digital Ltd. BTCT	FY2025	$14.0M	-$9.1M	-64.5%	$18.3M	17/100
Socket Mobile, Inc. New SCKT	FY2025	$15.1M	-$14.4M	-95.4%	$5.5M	37/100

Where Transact Technologies Inc Ranks

Frequently Asked Questions

What is Transact Technologies Inc's annual revenue?

Transact Technologies Inc (TACT) reported $51.5M in total revenue for fiscal year 2025. This represents a 18.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Transact Technologies Inc's revenue growing?

Transact Technologies Inc (TACT) revenue grew by 18.7% year-over-year, from $43.4M to $51.5M in fiscal year 2025.

Is Transact Technologies Inc profitable?

No, Transact Technologies Inc (TACT) reported a net income of -$1.2M in fiscal year 2025, with a net profit margin of -2.4%.

What is Transact Technologies Inc's EBITDA?

Transact Technologies Inc (TACT) had EBITDA of -$743K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Transact Technologies Inc's gross margin?

Transact Technologies Inc (TACT) had a gross margin of 48.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Transact Technologies Inc's operating margin?

Transact Technologies Inc (TACT) had an operating margin of -2.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Transact Technologies Inc's net profit margin?

Transact Technologies Inc (TACT) had a net profit margin of -2.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Transact Technologies Inc's return on equity (ROE)?

Transact Technologies Inc (TACT) has a return on equity of -4.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Transact Technologies Inc's free cash flow?

Transact Technologies Inc (TACT) generated $7.6M in free cash flow during fiscal year 2025. This represents a 391.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Transact Technologies Inc's operating cash flow?

Transact Technologies Inc (TACT) generated $7.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Transact Technologies Inc's total assets?

Transact Technologies Inc (TACT) had $44.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Transact Technologies Inc's capital expenditures?

Transact Technologies Inc (TACT) invested $109K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Transact Technologies Inc spend on research and development?

Transact Technologies Inc (TACT) invested $6.7M in research and development during fiscal year 2025.

How many shares does Transact Technologies Inc have outstanding?

Transact Technologies Inc (TACT) had 10M shares outstanding as of fiscal year 2025.

What is Transact Technologies Inc's current ratio?

Transact Technologies Inc (TACT) had a current ratio of 2.97 as of fiscal year 2025, which is generally considered healthy.

What is Transact Technologies Inc's debt-to-equity ratio?

Transact Technologies Inc (TACT) had a debt-to-equity ratio of 0.44 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Transact Technologies Inc's return on assets (ROA)?

Transact Technologies Inc (TACT) had a return on assets of -2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Transact Technologies Inc's P/E ratio?

Transact Technologies Inc (TACT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $47.4M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Transact Technologies Inc's price-to-sales ratio?

Transact Technologies Inc (TACT) trades at 0.9x sales, its market capitalization divided by revenue of $53.0M revenue, trailing 12 months to June 30, 2026. The market capitalization is $47.4M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Transact Technologies Inc's Altman Z-Score?

Transact Technologies Inc (TACT) has an Altman Z-Score of 3.92, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Transact Technologies Inc's Piotroski F-Score?

Transact Technologies Inc (TACT) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Transact Technologies Inc's earnings high quality?

Transact Technologies Inc (TACT) reported a net loss of $1.2M while generating $7.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Transact Technologies Inc cover its interest payments?

Transact Technologies Inc (TACT) reported an operating loss of $1.4M against $339K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Transact Technologies Inc?

Transact Technologies Inc (TACT) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.